Evidence map›Paper›PMID 33982322›Full record

ArticleHepatology (Baltimore, Md.)2021

Doxycycline Significantly Enhances Induction of Induced Pluripotent Stem Cells to Endoderm by Enhancing Survival Through Protein Kinase B Phosphorylation.

Caitlin Peaslee, Cristina Esteva-Font, Tao Su, Antonio Munoz-Howell, Caroline C Duwaerts, Zhe Liu, Sneha Rao, Ke Liu, Marisa Medina, Julie B Sneddon and 2 more

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanisms of Differential Signal Transduction by IFNLR1 Variants.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Function of Interferon Lambda Receptor 1 Variants in Stem Cell-Derived Hepatocytes with Abrogated EndogenousJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Caitlin Peaslee *Department of Pathology, University of California San Francisco, San Francisco, CA.
Cristina Esteva-Font *Department of Pathology, University of California San Francisco, San Francisco, CA.
Tao Su *Department of Pathology, University of California San Francisco, San Francisco, CA.
Antonio Munoz-HowellChildren's Hospital Oakland Research Institute, University of California San Francisco, San Francisco, CA.
Caroline C DuwaertsDepartment of Medicine, University of California San Francisco, San Francisco, CA.
Zhe LiuDepartment of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA.
Sneha RaoDepartment of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA.
Ke LiuChildren's Hospital Oakland Research Institute, University of California San Francisco, San Francisco, CA.
Marisa MedinaChildren's Hospital Oakland Research Institute, University of California San Francisco, San Francisco, CA.
Julie B SneddonDepartment of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA.
Jacquelyn J MaherDepartment of Medicine, University of California San Francisco, San Francisco, CA.
Aras N MattisDepartment of Pathology, University of California San Francisco, San Francisco, CA.
University of California, San Francisco · USBroad Center · US

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Y. Chen · 1986 to 2026
$30.7M
UCSF Environmental Research and Translation for Health Center (EaRTH Center)P30ES030284 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JENNIFER C FUNG, Tracey J. Woodruff · 2020 to 2026
$11.2M
A novel progenitor population in pancreatic endocrine cell developmentR01DK118421 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SNEDDON, JULIE BETH · 2019 to 2023
$2.1M
Regulation of Lipid Metabolism by miR-29a within HepatocytesK08DK098270 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTIS, ARAS NIKODEMAS · 2013 to 2017
$789k
Using disease-specific iPS cells to investigate fatty liver disease in a diverse human cohortR21DK118380 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MAHER, JACQUELYN J. · 2018 to 2019
$441k
NIDDK NIH HHS K08 DK098270NIDDK NIH HHS P30 DK026743NIDDK NIH HHS R01 DK118421NIDDK NIH HHS R21 DK118380NIEHS NIH HHS P30 ES030284
6 · The paper itself

Abstract

BACKGROUND AND

aimsInduced pluripotent stem cells (iPSCs) provide an important tool for the generation of patient-derived cells, including hepatocyte-like cells, by developmental cues through an endoderm intermediate. However, most iPSC lines fail to differentiate into endoderm, with induction resulting in apoptosis. APPROACH AND

resultsTo address this issue, we built upon published methods to develop an improved protocol. We discovered that doxycycline dramatically enhances the efficiency of iPSCs to endoderm differentiation by inhibiting apoptosis and promoting proliferation through the protein kinase B pathway. We tested this protocol in >70 iPSC lines, 90% of which consistently formed complete sheets of endoderm. Endoderm generated by our method achieves similar transcriptomic profiles, expression of endoderm protein markers, and the ability to be further differentiated to downstream lineages.

conclusionsFurthermore, this method achieves a 4-fold increase in endoderm cell number and will accelerate studies of human diseases in vitro and facilitate the expansion of iPSC-derived cells for transplantation studies.

Indexed as

EndodermAnti-Bacterial AgentsApoptosisCell Culture TechniquesCell DifferentiationCell LineCell LineageDoxycyclineHumansInduced Pluripotent Stem CellsProto-Oncogene Proteins c-aktSignal TransductionTreatment OutcomeAnti-Bacterial AgentsDoxycyclineProto-Oncogene Proteins c-akt

Identifiers

PMID33982322
PMCPMC8544023
OpenAlexW3161669231

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.